Top ▲
 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Ligand name | ID | Synonyms | |||||||
| A | Back to top | ||||||||
| [3H]A317491 |   |   |   | 5407 | [3H]A 317491, [3H]A-317491 | ||||
| [3H]A-585539 |   |   | 3974 | ||||||
| [3H]A778317 |   |   | 4076 | ||||||
| [3H]A804598 |   |   | 5408 | [3H]A 804598 | |||||
| [3H]A81988 |   |   | 3938 | [3H]-A81988 | |||||
| [125I]AB-MECA |   |   | 436 | [125I]-AB-MECA, [125I]5-[6-[(4-aminophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide, [125I]N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide | |||||
| [125I]ABOPX |   |   | 452 | [125I]3-(3,4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine | |||||
| Ac-[13C,15N]PGP |   |   | 12599 | ||||||
| [3H]acetylcholine |   |   |   | 8593 | |||||
| [14C]acetylCoA |   |   | 4541 | [14C]-acetylCoA | |||||
| [125I][Ac-His1]PACAP-27 |   |   | 2260 | [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||
| [35S]ACPPB |   |   | 4584 | [35S]-ACPPB | |||||
| [125I]ACTH-(1-24) |   |   | 3767 | [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24) | |||||
| [3H]AD5075 |   |   | 2702 | [3H]-AD5075 | |||||
| [35S]ADPβS |   |   | 3408 | ||||||
| [125I]adrenomedullin |   |   | 3768 | [125I]-adrenomedullin, [125I]-AM | |||||
| [3H]AF DX-384 |   |   | 368 | [3H]AF-DX 384 | |||||
| [125I][Ala1,3,11,15]ET-1 |   |   | 3760 | [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1 | |||||
| β-Ala-Lys-AMCA |   | 9501 | β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA | ||||||
| [14C]alanine |   |   |   | 4542 | [14C]-alanine | ||||
| [3H]alanine |   |   |   | 4543 | [3H]-alanine | ||||
| [3H]aldosterone |   |   |   | 3452 | [3H]-aldosterone | ||||
| Alexa-488-telenzepine |   | 8600 | |||||||
| [3H]-almorexant |   |   | 9465 | ||||||
| [3H]alniditan |   |   | 117 | R-91274 | |||||
| [18F]altanserin |   |   | 3242 | [18F]altanserin (PET ligand) | |||||
| [123I]AM251 |   |   | 744 | ||||||
| [3H]AMPA |   |   | 4077 | ||||||
| [125I]amylin |   |   | 3770 | [125I]-BH-AMY, [125I]-Bolton Hunter amylin | |||||
| [3H]ancriviroc |   |   | 802 | [3H]SCH 351125, [3H]Sch-351125 | |||||
| [125I]angiotensin-(1-7) (human, mouse, rat) |   |   | 5578 | [125I]ang-(1-7) | |||||
| [125I]ANP (human) |   |   | 4845 | [125I]-ANP | |||||
| [125I]antisauvagine |   |   | 930 | ||||||
| [3H]AP4 |   |   |   | 1412 | |||||
| [3H]apafant |   |   | 1859 | [3H]WEB 2086 | |||||
| [125I]apelin-13 |   |   | 602 | ||||||
| [125I]APNEA |   |   | 462 | [3H]N6-2-(4-aminophenyl)ethyladenosine | |||||
| [14C]ascorbic acid |   |   |   | 4532 | [14C]-ascorbic acid | ||||
| [125I]astressin |   |   | 924 | ||||||
| [35S]ATPαS |   |   | 3407 | [35S]-ATPαS | |||||
| [35S]ATPγS |   |   | 5406 | [35S]-ATPgammaS | |||||
| [3H]AVP (human, mouse, rat) |   |   | 2175 | [3H]arginine vasopressin | |||||
| [11C]AZ10419369 |   |   | 3926 | [11C]AZ10419369 (PET ligand) | |||||
| [3H]AZ11637326 |   |   | 3971 | ||||||
| [3H]AZ12464237 |   |   | 14167 | [3H]AZ12464237 | |||||
| [125I]7-azido-8-iodoketanserine |   |   | 4763 | [125I]-7-azido-8-iodoketanserine (photoaffinity ligand), [125I]azidoiodoketanserin, [125I]AZIK | |||||
| [3H]azietomidate |   |   | 5404 | ||||||
| B | Back to top | ||||||||
| [3H](R)-(-)-baclofen |   |   |   | 3428 | |||||
| [3H]bag-2 |   |   | 8506 | ||||||
| [125I]bantag-1 |   |   | 11435 | ||||||
| [3H]banyu (I) |   |   | 795 | ||||||
| BAY86-7548 |   |   | 11260 | [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2 | |||||
| [125I]BAY 55-9837 |   |   | 2281 | ||||||
| [125I]BDNF (human) |   |   | 4846 | [125I]-BDNF, [125I]-brain-derived neurotrophic factor | |||||
| [125I]-BDZ2 |   |   | 6667 | ||||||
| [125I]BgK (W5Y / Y26F) |   |   | 2565 | ||||||
| [125I]BH-MIT1 |   |   | 8522 | ||||||
| [125I]BH-NMB (human, mouse, rat) |   |   | 3771 | [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B | |||||
| [125I]BH-[Sar9,Met(O2)11]SP |   |   | 3769 | [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P | |||||
| [3H]BH-[Sar9,Met(O2)11]SP |   |   | 3811 | [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP | |||||
| [3H]BIBP3226 |   |   | 3474 | [3H]-BIBP3226 | |||||
| [125I]BIM23027 |   |   | 3772 | [125I]-BIM 23027, [125I]-BIM23027 | |||||
| [3H]BK (human, mouse, rat) |   |   | 3812 | [3H]-BK, [3H]-bradykinin | |||||
| BODIPY FL-prazosin |   | 13134 | QAPB | ||||||
| BODIPY-pirenzepine |   | 8604 | Bodipy[558/568]Pirenzepine, BoPz | ||||||
| [125I]BOP |   |   | 1973 | [125I]-I-BOP | |||||
| [Bpa6,Tyr10]secretin-27 (rat) |   |   | 1154 | ||||||
| [125I]BQ3020 |   |   | 1005 | [125I]-BQ3020 | |||||
| [3H]BQ123 |   |   | 1003 | [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu | |||||
| [3H]brimonidine (UK14304) |   |   |   | 5386 | [3H]-UK14304 | ||||
| [3H]BSP |   |   | 4505 | [3H]-BSP, bromosulfophthalein | |||||
| [125I]α-bungarotoxin |   |   | 3972 | ||||||
| [3H]α-bungarotoxin |   |   | 3981 | ||||||
| [125I]buserelin |   |   | 1167 | [125I]-buserelin | |||||
| [11C]butylthio-TZTP |   |   | 3268 | [11C]butylthio-TZTP (PET ligand) | |||||
| [3H]BWA868C |   |   | 1899 | ||||||
| C | Back to top | ||||||||
| [125I]C3a (human) |   |   | 3773 | [125I]-C3a | |||||
| [125I]C5a (human) |   |   | 3774 | [125I]-C5a | |||||
| [125I]calcitonin |   |   | 3776 | [125I]-calcitonin (Human), [125I]-CT (Human) | |||||
| [125I]calcitonin (salmon) |   |   | 3777 | [125I]-calcitonin (Salmon), [125I]-CT (Salmon) | |||||
| [3H]cAMP |   |   |   | 5096 | [3H]-cAMP | ||||
| [3H]candesartan |   |   | 6907 | ||||||
| [125I]cathepsin G (human) |   |   | 1017 | [125I]cathepsin G | |||||
| [3H]CCK-8 (human, mouse, rat) |   |   | 4765 | [3H]-CCK-8 | |||||
| [125I]CCL11 (human) |   |   | 794 | [125I]eotaxin | |||||
| [125I]CCL16 (human) |   |   | 1275 | [125I]LEC | |||||
| [125I]CCL17 (human) |   |   | 3652 | [125I]TARC | |||||
| [125I]CCL19 (human) |   |   | 3655 | [125I]ELC | |||||
| [125I]CCL1 (human) |   |   | 814 | [125I]I-309, [125I]P500, [125I]TCA-3 | |||||
| [125I]CCL20 (human) |   |   | 3654 | [125I]LARC, [125I]MIP-3α | |||||
| [125I]CCL21 (human) |   |   | 3656 | [125I]SLC | |||||
| [125I]CCL25 (human) |   |   | 3657 | [125I]TECK | |||||
| [125I]CCL27 (human) |   |   | 3653 | [125I]CTACK | |||||
| [125I]CCL2 (human) |   |   | 762 | [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1 | |||||
| [125I]CCL3 (human) |   |   | 763 | [125I]macrophage inflammatory protein-1α, [125I]MIP-1α | |||||
| [125I]CCL4 (human) |   |   | 799 | [125I]macrophage inflammatory protein-1β, [125I]MIP-1β | |||||
| [125I]CCL5 (human) |   |   | 764 | [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted | |||||
| [125I]CCL7 (human) |   |   | 765 | [125I]MCP-3, [125I]monocyte chemotactic protein-3 | |||||
| [125I]CCL8 (human) |   |   | 766 | [125I]MCP-2, [125I]monocyte chemotactic protein-2 | |||||
| [125I]CCL1 (mouse) |   |   | 5546 | ||||||
| [3H]CCPA |   |   | 379 | [3H]-CCPA | |||||
| [125I]cetrorelix |   |   | 1186 | ||||||
| [125I]CGP 23996 |   |   | 2022 | ||||||
| [125I]CGP42112 |   |   | 594 | [125I]-CGP42112, Cgp 42112B, Cgp-42112A | |||||
| [125I]CGP64213 |   |   | 1076 | ||||||
| [125I]CGP71872 |   |   | 1077 | CGP 71872 | |||||
| [3H](-)CGP 12177 |   |   | 531 | ||||||
| [3H]CGP12177 |   |   | 5387 | [3H]-CGP12177, [3H]CGP 12177 | |||||
| [3H]CGP27492 |   |   | 5381 | [3H]-3-APPA, [3H]-CGP27492, [3H]3-APPA | |||||
| [3H]CGP39653 |   |   | 4078 | ||||||
| [3H]CGP54626 |   |   |   | 1090 | |||||
| [3H]CGP61594 |   |   | 4079 | [3H]CGP 61594 | |||||
| [3H]CGP62349 |   |   | 3429 | [3H]-CGP 62349 | |||||
| [125I]αCGRP |   |   | 3766 | [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP | |||||
| [125I]αCGRP (mouse, rat) |   |   | 6567 | ||||||
| [3H]CGS19755 |   |   | 4080 | ||||||
| [3H]CGS 21680 |   |   |   | 424 | [3H]-CGS21680 | ||||
| [3H]CGS23131 |   |   | 3415 | [3H]CGS 23131, [3H]-CGS23131, LY223982 | |||||
| [3H]CGS8216 |   |   | 4366 | ||||||
| chenodeoxycholyl-Nε-nitrobenzoxadiazol-lysine |   | 4770 | |||||||
| [125I]CHIPS |   |   | 1027 | [125I]chemotaxis inhibitory protein of S. aureus | |||||
| [125I]chorionic gonadotropin (human) |   |   | 3775 | [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin | |||||
| [3H](+)-cis-diltiazem |   |   | 2512 | [3H]-(+)-cis-diltiazem | |||||
| [3H]9-cis-retinoic acid |   |   |   | 5383 | [3H]-9-cis-retinoic acid | ||||
| [3H]citalopram |   |   | 4621 | [3H]-citalopram | |||||
| [3H]clidinium |   |   | 351 | (-)MQNB, [3H](-)N-methyl-3-quinuclidinyl benzilate, Ro-23773 | |||||
| [3H]clonidine |   |   |   | 13162 | |||||
| [125I]CNP (human) |   |   | 4847 | [125I]-CNP | |||||
| [3H]CNQX |   |   |   | 4081 | |||||
| [125I]α-conotoxin MII |   |   | 3975 | ||||||
| [3H] corticosterone |   |   | 13966 | 1,2,6,7-(3H) corticosterone | |||||
| [3H] cortisol |   |   | 13965 | 1,2,6,7-(3H)Cortisol | |||||
| [3H]Cp-1 |   |   | 9466 | ||||||
| [3H]CP55940 |   |   |   | 734 | |||||
| [3H]CPP |   |   | 4082 | ||||||
| [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP |   |   | 3921 | [125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP | |||||
| [125I]CRF (ovine) |   |   | 915 | [125I]corticotropin | |||||
| [3H]5-CT |   |   | 262 | [3H]5-carboxamidotryptamine, tritiated 5-carbamidotryptamine | |||||
| [3H]CTEP |   |   | 6408 | ||||||
| [3H]CTOP |   |   | 12512 | ||||||
| [125I]CXCL10 (human) |   |   | 3660 | [125I]IP-10 | |||||
| [125I]CXCL11 (human) |   |   | 3661 | [125I]I-TAC | |||||
| [125I]CXCL12α (human) |   |   | 849 | [125I]SDF-1α (human), [125I]stromal cell-derived factor-1α | |||||
| [125I]CXCL12β (human) |   |   | 850 | [125I]SDF-1β (human), [125I]stromal cell-derived factor-1β | |||||
| [125I]CXCL16 (human) |   |   | 3662 | ||||||
| [125I]CXCL1 (human) |   |   | 3677 | [125I]GROα | |||||
| [125I]CXCL5 (human) |   |   | 3659 | [125I]ENA-78 | |||||
| [125I]CXCL7 (human) |   |   | 3658 | [125I]NAP-2 | |||||
| [125I]CXCL8 (human) |   |   | 822 | [125I]IL-8, [125I]interleukin-8 | |||||
| [125I]CX3CL1 (human) |   |   | 3664 | [125I]Fractalkine | |||||
| [125I]CXCL13 (mouse) |   |   | 8631 | ||||||
| Cy3B-NMU-8 |   | 3863 | |||||||
| Cy3B-telenzepine |   | 8598 | |||||||
| [Cy5-Lys19]NPS |   | 9166 | Cy5-hNPS | ||||||
| [3H]cytisine |   |   | 3979 | ||||||
| D | Back to top | ||||||||
| [3H][D-Ala2]deltorphin I |   |   | 9065 | ||||||
| D-Ala-Lys-AMCA |   | 5421 | (D)-Ala-(L)-Lys-Nε-AMCA, D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid | ||||||
| [3H]DAMGO |   |   | 3815 | [3H]-DAMGO, [tyrosyl 3,5-3H]DAMGO | |||||
| [3H]4-DAMP |   |   | 11497 | ||||||
| [3H]darifenacin |   |   | 319 | ||||||
| [3H]D-aspartic acid |   |   |   | 4698 | [3H]-D-aspartate, [3H]-D-aspartic acid | ||||
| [35S]dATPαS |   |   | 3406 | [35S]-dATPαS | |||||
| [3H]d[Cha4]AVP |   |   | 2227 | [3H][1-deamino-4-cyclohexylalanine]AVP, [3H][deamino-Cys1,Cha4]AVP | |||||
| [125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP |   |   | 2230 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP | |||||
| [125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP |   |   | 2231 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP | |||||
| [125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP |   |   | 2232 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP | |||||
| [125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP |   |   | 2233 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | |||||
| [3H]d(CH2)5[Tyr(Me)2]AVP |   |   | 3813 | [3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP | |||||
| [125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT |   |   | 3778 | [125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT | |||||
| d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT |   |   | 2218 | β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT, [125I]ZOTA, d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin | |||||
| d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT |   |   | 2220 | [125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin, [125I]OTA | |||||
| [3H]d[D-Arg8]VP |   |   | 5403 | [3H]-d[D-Arg8]VP, [3H][D-Arg8]vasopressin, [3H]DAVP | |||||
| [3H]dDAVP |   |   | 2228 | [3H]deamino arginine vasopressin, [3H]desmopressin | |||||
| [3H]dehydroepiandrosterone sulphate |   |   | 5577 | [3H]DHEAS, [3H]dehydroepiandrosterone sulfate | |||||
| [3H]deltorphin II |   |   | 3816 | [3H]-deltorphin II | |||||
| [3H]2-deoxyglucose |   |   | 4643 | 2-deoxy-D-glucose, 2-DG, [3H]-2-deoxyglucose | |||||
| [125I][des-Gly10,D-Ala6]GnRH N-ethylamide |   |   | 1166 | ||||||
| [3H]desGly-NH2[D-Ile2,Ile4]VP |   |   | 3817 | [3H]-desGly-NH2[D-Ile2,Ile4]AVP | |||||
| [3H](-)devapamil |   |   | 2515 | ||||||
| [3H]devazepide |   |   | 3476 | [3H]-devazepide | |||||
| [3H]dexamethasone |   |   |   | 3447 | [3H]-dexamethasone | ||||
| [3H]digoxin |   |   |   | 4725 | [3H]-digoxin | ||||
| [3H]dihydroalprenolol |   |   | 5388 | [3H]-dihydroalprenolol | |||||
| [3H]dihydrotestosterone |   |   |   | 3455 | [3H]-dihydrotestosterone | ||||
| [3H]dimethyl-W84 |   |   | 364 | ||||||
| [3H]-di-o-tolylguanidine |   |   | 6685 | [3H]DOTG | |||||
| [3H]diprenorphine |   |   | 1612 | [15,16-3H]diprenorphine | |||||
| [125I]DIV880 |   |   | 7771 | ||||||
| [3H]dizocilpine |   |   | 4089 | [3H]MK-801 | |||||
| [125I]1DMe |   |   | 1483 | ||||||
| [3H](+)DOB |   |   | 155 | 4-bromo-2,5-dimethoxyphenylisopropylamine, brolamfetamine | |||||
| [125I]DOI |   |   | 169 | ||||||
| [111In]DOTA-BOC-ATE |   |   | 2063 | [111In-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE | |||||
| [111In]DOTA-dLVT |   |   | 3756 | [111In]-DOTA-dLVT, [111In]-DOTA-Lys8-deamino-vasotocin, [111indium]DOTA-dLVT | |||||
| DOTA/Eu relaxin-3 |   | 11912 | |||||||
| [111In,90Y]DOTA-LAN |   |   | 2056 | DOTA-conjugated peptide, YIII-DOTA-LAN | |||||
| [111In]DOTA-NOC |   |   | 2045 | [111In-DOTA]-NOC, [InIII-DOTA]-NOC, [InIII-DOTA]-NOC | |||||
| [111In,90Y]DOTA-NOC |   |   | 2057 | 90Y-DOTA-NOC, [90Y-DOTA]-1-Nal3-octreotide, YIII-DOTA-NOC | |||||
| [111In]DOTA-NOC-ATE |   |   | 2064 | [111In-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE | |||||
| [111In,90Y]DOTA-OC |   |   | 2058 | [3Y]DOTA-OC, [3Y]DOTA-octreotide, YIII-DOTA-OC | |||||
| [111In,90Y]DOTA-TOC |   |   | 2059 | YIII-DOTA-TOC, YIII-DOTA-Tyr3-octreotide, YIII-DOTA-TOC | |||||
| [11C]doxepin |   |   |   | 3958 | [11C]-doxepin | ||||
| [3H]DPCPX |   |   | 406 | [3H]-DPCPX | |||||
| [3H]DPDPE |   |   | 3819 | [3H]-[d-Pen2,d-Pen5]-Enkephalin, [3H]-DPDPE | |||||
| [11C]DTBZ |   |   | 4608 | [11C]-DTBZ , [11C]-DTBZ (PET ligand), dihydrotetrabenazine | |||||
| [125I]α-DTX |   |   | 2564 | ||||||
| [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14) |   |   | 631 | [125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14, [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14) | |||||
| [125I][D-Tyr6]bombesin-(6-13)-methyl ester |   |   | 628 | ||||||
| [d-Tyr-14C]TAK-448 |   |   | 10223 | ||||||
| [125I]DTyr-Gly-[(Nle28,31)CCK-26-33 |   |   | 6666 | ||||||
| E | Back to top | ||||||||
| [125I]EGF (human) |   |   | 4848 | [125I]-epidermal growth factor | |||||
| [3H]eglumegad |   |   |   | 1396 | [3H]LY354740 | ||||
| [3H]eletriptan |   |   | 118 | ||||||
| [3H]EMPA |   |   | 9467 | ||||||
| [3H]EM-TBPC |   |   | 1390 | ||||||
| [3H]enadoline |   |   | 3475 | [3H]-CI977, [3H]-enadoline, [3H]CI-977, [3H]CI977 | |||||
| [125I]epibatidine |   |   | 3976 | ||||||
| [3H]epibatidine |   |   | 3977 | ||||||
| [3H]eprosartan |   |   | 3940 | [3H]-eprosartan, [3H]SK&F 108566 | |||||
| [3H]17β-estradiol |   |   |   | 1012 | [3H]-estradiol, [3H]-estrogen, [3H]E2, [3H]estradiol | ||||
| [3H]estradiol-17β-glucuronide |   |   |   | 4687 | [3H]-estradiol-17β-glucuronide | ||||
| [3H]estrone-3-sulphate |   |   | 4748 | [3H]-estrone hydrogen sulfate, [3H]-estrone-3-sulphate, [3H]estrone-3-sulfate | |||||
| [3H]ETB-TBOA |   |   | 4492 | [3H]-ETB-TBOA | |||||
| [125I]ET-2 (human) |   |   | 992 | [125I]endothelin-2 | |||||
| [125I]ET-1 (human, mouse, rat) |   |   | 991 | [125I]endothelin-1 | |||||
| [18F]ET-1 (human, mouse, rat) |   |   | 994 | [18F]endothelin-1 | |||||
| Eu-DTPA-hC3a |   | 11286 | |||||||
| Eu-DTPA-[Ser27, Nle70]hC5a |   | 12516 | |||||||
| europium-labelled INSL3 |   | 3875 | |||||||
| europium-labelled INSL5 |   | 4375 | |||||||
| europium-labelled mouse INSL5 |   | 6522 | |||||||
| europium-labelled R3(B1-22R) |   | 8342 | Eu R3(B1-22R) | ||||||
| europium-labelled relaxin |   | 3874 | europium-labelled H2 relaxin | ||||||
| europium-labelled relaxin-3-B/INSL5 A chimera |   | 4374 | Eu-R3/I5, europium-labelled H3-B/INSL5 A chimera | ||||||
| [125I]exendin-(9-39) |   |   | 1137 | [125I]exendin (9-39) | |||||
| [125I]EXP985 |   |   | 3942 | [125I]-EXP985 | |||||
| [125I]EYF |   |   | 1488 | [125I]-EYF | |||||
| [3H]EYF |   |   | 4021 | [3H]-EYF | |||||
| F | Back to top | ||||||||
| [3H]fananserin |   |   | 3229 | [3H]RP-62203, [3H]RP62203 | |||||
| [3H]fenobam |   |   |   | 1433 | |||||
| [18F]FEPPG |   |   | 11367 | (S)-N-(2-amino-3-(4-(2-(fluoro-18F)ethoxy)phenyl)propanoyl)-N-methylglycine | |||||
| [18F]FITM |   |   | 6213 | ||||||
| florbetaben |   |   |   | 7769 | [18F]BAY 94-9172, AV-1, BAY 94-9172, Neuraceq® | ||||
| florbetapir |   |   |   | 7344 | AMYViD®, AV-45, florbetapir (18F) | ||||
| flortaucipir (18F) |   |   |   | 9100 | 18F-AV-1451, [F-18]T807, flortaucipir F-18, LY-3191748, Tauvid® | ||||
| F2L-[125I]Tyr |   |   | 1045 | ||||||
| Flu-CCL3 |   | 760 | Flu-LD78α, Flu-MIP-1α, fluorescent macrophage inflammatory protein-1α | ||||||
| [11C]flumazenil |   |   |   | 4367 | [11C]flumazenil (PET ligand) | ||||
| [3H]flunitrazepam |   |   | 4360 | ||||||
| fluorescent MIF ligand B |   |   | 9987 | ||||||
| [18F]fluoroethylflumazenil |   |   | 4368 | [18F]fluoroethylflumazenil (PET ligand) | |||||
| [3H](+)-fluprostenol |   |   | 3417 | [3H]-(+)-fluprostenol | |||||
| flutemetamol |   |   |   | 7342 | 18F-flutemetamol, [18F]flutemetamol, flutemetamol F18 | ||||
| [18F]FMBP |   |   | 12670 | ||||||
| [3H]fMet-Leu-Phe |   |   | 1018 | [3H]fMet-Leu-Phe, [3H]fMLP | |||||
| fMet-Leu-Phe-Ile-Ile-Lys-FITC |   | 5843 | |||||||
| [3H]folic acid |   |   |   | 4562 | [3H]-folic acid | ||||
| [3H]folinic acid |   |   | 6690 | ||||||
| (3,5)-[19F]2-Phe-ψ-Ala |   |   | 11370 | (3,5)-difluoro Phe-ψ-Ala | |||||
| [18F]FPIT |   |   | 6392 | ||||||
| [18F]FP-TZTP |   |   | 3266 | [18F]FP-TZTP (PET ligand) | |||||
| [125I]FSH (human) |   |   | 3780 | [125I]-follicle-stimulating hormone, [125I]-FSH | |||||
| 2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 |   | 4050 | Alexa Fluor 594-2fLI | ||||||
| [3H]2-furoyl-LIGRL-NH2 |   |   | 6660 | ||||||
| 2-furoyl-LIGRL[N[3H]propionyl]-O-NH2 |   |   | 4049 | [3H]propionyl-2fLI | |||||
| G | Back to top | ||||||||
| [3H]GABA |   |   |   | 5410 | |||||
| [3H]gabazine |   |   | 4083 | SR95531 | |||||
| [125I]gastrin |   |   | 3781 | [125I]-gastrin | |||||
| [3H]gastrin |   |   | 3821 | [3H]-gastrin | |||||
| [3H]GBR12935 |   |   | 4638 | [3H]-GBR12935 | |||||
| [125I]GDNF (rat) |   |   | 4851 | [125I]-GDNF (rat) | |||||
| GE-137 |   | 8585 | |||||||
| [125I]GHRH (human) |   |   | 3783 | [125I]-GHRH, [125I]-growth hormone releasing hormone, [125I]-Tyr10-hGHRH(1-44)NH2, [125I]GHRH(1-44)NH2 | |||||
| [125I]GIP (human) |   |   | 1131 | [125I]-GIP, [125I]gastric inhibitory polypeptide | |||||
| [125I]GLP-1-(7-36)-amide |   |   | 1134 | [125I]GLP-1, [125I]GLP-1(7-36)amide, [125I]glucagon-like peptide 1 (7-36) | |||||
| [125I]GLP-1-(7-37) (human) |   |   | 3784 | [125I]-GLP-1(7-37), [125I]-glucagon-like peptide-1(7-37), [125I]GLP-1(7-37) | |||||
| [125I][Glp65Nle75,Tyr77]apelin-13 |   |   | 3761 | [125I](Pyr1)[Nle75,Tyr77]-apelin-13, [125I]-[Glp65Nle75,Tyr77]apelin-13, [125I][Glu65,Nle75,Tyr77]apelin-13 | |||||
| [125I]glucagon (human, mouse, rat) |   |   | 3785 | [125I]-glucagon | |||||
| [14C]glutamine |   |   |   | 4633 | [14C]-glutamine | ||||
| [3H]glutamine |   |   |   | 4634 | [3H]-glutamine | ||||
| [14C]glycine |   |   |   | 4635 | [14C]-glycine | ||||
| [3H]glycine |   |   |   | 4084 | |||||
| glycyl-[13C3]-sarcosine |   |   | 12598 | ||||||
| [11C]GlySar |   |   | 4489 | [11C]-GlySar, [11C]glycylsarcosine | |||||
| [14C]GlySar |   |   | 4599 | [14C]-GlySar, glycylsarcosine | |||||
| [3H]GlySar |   |   | 4659 | [3H]-GlySar, tritiated glycylsarcosine | |||||
| [125I]GnRH I (human, mouse, rat) |   |   | 3786 | [125I]-GnRH I, [125I]-gonadotropin-releasing hormone I | |||||
| [125I]GnRH II (human) |   |   | 3787 | [125I]-GnRH II, [125I]-gonadotropin-releasing hormone II | |||||
| [125I]GR231118 |   |   | 1531 | [125I]1229U91, [125I]GW1229 | |||||
| [3H]GR100679 |   |   | 3822 | [3H]-GR100679 | |||||
| [3H]GR 113808 |   |   | 259 | GR 125487 [H3], GR113808 | |||||
| [3H]GR 125,743 |   |   | 131 | [3H]GR125743, GR125743 | |||||
| [3H]GR65630 |   |   | 2303 | [3H]-GR65630 | |||||
| [3H]granisetron |   |   | 2292 | [3H]-BRL-43694, [3H]-granisetron | |||||
| [125I]GRP (human) |   |   | 3788 | [125I]-gastrin-releasing peptide, [125I]-GRP | |||||
| [11C]GSK215083 |   |   | 8430 | ||||||
| [3H]GSK931145 |   |   | 4490 | [3H]-GSK931145 | |||||
| [125I]GTI |   |   | 3250 | serotonin-5-O-carboxymethyl-glycyl-(125I)tyrosinamide | |||||
| [3H]GW2331 |   |   | 2706 | ||||||
| H | Back to top | ||||||||
| [3H]haTRAP |   |   | 3823 | [3H]-haTRAP, Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide | |||||
| HEAT (BE2254) |   |   | 482 | [125I] BE2254, [125I] HEAT, [125I]-HEAT, [125I]BE2254 | |||||
| [125I]HEAT (BE2254) |   |   | 500 | 2-[[2-(4-hydroxy-3-iodanylphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one, 2-{p-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl}-tetralone, [125I]BE-2254, HEAT | |||||
| [3H]HEMADO |   |   | 5736 | ||||||
| [3H]hemicholinium-3 |   |   | 4493 | [3H]-HC-3 , [3H]-hemicholinium-3, [3H]HC-3 | |||||
| [125I][His9]ghrelin (human) |   |   | 1094 | [125I-His9]ghrelin, [125I] His9-ghrelin (human) | |||||
| [3H]histamine |   |   |   | 1247 | |||||
| [14C]histidine |   |   | 4623 | [14C]-histidine | |||||
| [3H]histidine |   |   | 4670 | [3H]-histidine | |||||
| [125I]Hpp-desArg10HOE140 |   |   | 3791 | [125I]-Hpp-desArg9HOE140 | |||||
| [125I]HPP-HOE140 |   |   | 11436 | [125I]-3-4-hydroxyphenyl-propionyl-d-Arg0-[Hyp3,Thi5,d-Tic7,Oic8]bradykinin | |||||
| [125I]-HPP-icatibant |   |   | 11158 | [(125)I]-HPP-Hoe 140, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-BK, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin, [125I]3-4 hydroxyphenyl-propionyl-icatibant | |||||
| [3H]5-HT |   |   | 3248 | [3H]-5-HT | |||||
| [3H]HU-243 |   |   | 735 | ||||||
| I | Back to top | ||||||||
| [35S]ibutamoren |   |   | 1097 | [35S]MK-0677 | |||||
| [3H]ICI-198615 |   |   | 3414 | [3H]-ICI198615, [3H]ICI-198,615, [3H]ICI198615 | |||||
| ICOA-13 |   | 11196 | |||||||
| [125I]ICYP |   |   | 562 | [125I]cyanopindolol, [125I]iodocyanopindolol | |||||
| [3H]iloprost |   |   | 1966 | [3H]-Iloprost, [3H]ciloprost, [3H]ventavis | |||||
| [125I]INSL3 (human) |   |   | 1996 | ||||||
| [125I]INSL5 (human) |   |   | 2001 | [125I]insulin-like peptide 5 | |||||
| iodipamide |   |   |   | 7400 | adipiodone meglumine, iodipamic acid, radio-cholografin | ||||
| [125I]iodoaminopotentidine |   |   | 1230 | [125I]-iodoaminopotentidine, [125I]APT | |||||
| [123I]iodobenzovesamicol |   |   | 4762 | [123I]-IBVM, [123I]-iodobenzovesamicol | |||||
| 2-iodo-[125I]5MCA-NAT |   |   | 5396 | 2-iodo-[125I]-5MCA-NAT | |||||
| [125I]iodophenpropit |   |   | 3960 | ||||||
| [123I]iodoproxyfan |   |   | 1264 | [125I]-iodoproxyfan | |||||
| [125I](3-iodo-Tyr13)-MCH |   |   | 1316 | ||||||
| [125I]iodovinyl-TBZ |   |   | 4764 | [125I]-iodovinyl-TBZ , [125I]-iodovinyltetrabenazine | |||||
| [3H]iperoxo |   |   | 12486 | ||||||
| [3H]-IPP |   |   | 11368 | ||||||
| [3H]irbesartan |   |   | 6908 | ||||||
| [125I]IRL1620 |   |   | 1007 | [125I]-IRL1620, [125I]IRL 1620 | |||||
| Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 |   | 12493 | |||||||
| [3H](+)-isradipine |   |   | 2733 | (+)-[3H]isradipine, (+)-[3H]O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 3H-(+)-PN 200-110 | |||||
| [125I-Tyr]Ac2-26 |   |   | 6198 | [125I]ANXA1-derived peptide | |||||
| J | Back to top | ||||||||
| [3H]JB-93182 |   |   | 908 | ||||||
| [11C]JNJ-16567083 |   |   | 3418 | [11C]-JNJ-16567083 | |||||
| [3H]JNJ-40068782 |   |   | 6331 | ||||||
| [3H]JNJ 7777120 |   |   | 1279 | [3H]-JNJ7777120 | |||||
| K | Back to top | ||||||||
| [3H]kainate |   |   | 4085 | ||||||
| [125I]KC-Tyr |   |   | 832 | ||||||
| [3H]ketanserin |   |   |   | 197 | |||||
| [125I]kisspeptin-10 (human) |   |   | 1281 | [125I]-KP10, [125I]KP-10 | |||||
| [125I]kisspeptin-13 (human) |   |   | 3792 | [125I]-kisspeptin13, [125I]-KP13, [125I]KP13 | |||||
| [125I]kisspeptin-14 (human) |   |   | 4013 | [125I]KP14 | |||||
| [125I]kisspeptin-54 (human) |   |   | 1282 | [125I]KP-54, [125I]metastin | |||||
| L | Back to top | ||||||||
| [125I]L703,606 |   |   | 3471 | [125I]-L703,606, [125I]L703606 | |||||
| [125I]L750667 |   |   | 3295 | [125I]-L750667 | |||||
| [3H]L158809 |   |   | 3939 | [3H]-L158809, [3H]L-158,809 | |||||
| [3H]L365260 |   |   | 3477 | [3H]L-365,260 | |||||
| [3H]L655708 |   |   | 4363 | ||||||
| [3H]L689560 |   |   | 4086 | ||||||
| [3H]L748337 |   |   | 13196 | ||||||
| [3H]L-aspartic acid |   |   |   | 4534 | [3H]-L-aspartate, [3H]-L-aspartic acid | ||||
| LDV-FITC |   | 6759 | |||||||
| [3H]Leu-N/OFQ |   |   | 3824 | [3H]-Leu-N/OFQ, [3H]-Leu-nociceptin.orphanin FQ | |||||
| [125I][Leu31,Pro34]NPY |   |   | 3762 | [125I]-[Leu31,Pro34]neuropeptide Y, [125I]-[Leu31,Pro34]NPY | |||||
| [125I]LH |   |   | 3793 | [125I]-LH, [125I]-luteinising hormone, [125I]-luteinizing hormone | |||||
| [3H]-LKP |   |   | 11369 | ||||||
| [3H]losartan |   |   |   | 3941 | [3H]-losartan | ||||
| [3H]LPA |   |   | 5395 | [3H]-LPA, [3H]1-oleoyl-LPA, [3H]lysophosphatidic acid | |||||
| [125I]LSD |   |   | 261 | [125I]lysergamid, [125I]lysergic acid diethylamide, [125I]lysergide, [125I]N,N-diethyllysergamide | |||||
| [3H]LSD |   |   | 219 | [3H]lysergic acid diethylamide, [3H]lysergide, [3H]N,N-diethyllysergamide | |||||
| [3H]LTB4 |   |   | 3413 | ||||||
| [3H]LTC4 |   |   | 6195 | ||||||
| [3H]LTD4 |   |   | 3412 | [3H]-LTD4 | |||||
| [3H]LTE4 |   |   |   | 5863 | |||||
| [125I]LTT-SRIF-28 |   |   | 2023 | 3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28, 3-[125I]LTT-SRIF-28, [125I](Leu8, D-Trp22, Tyr25)-somatostatin-28 | |||||
| [3H]LXA4 |   |   | 3411 | [3H]-LXA4 | |||||
| [3H]LY278584 |   |   | 4087 | ||||||
| [3H]LY334370 |   |   | 151 | LY334370 | |||||
| [3H]LY341495 |   |   |   | 1399 | [3H]α-9'-xantheylmethyl-2-(carboxycyclopropyl)glycine | ||||
| [3H]Lys-[des-Arg9]BK |   |   | 3825 | [3H]-Lys-[des-Arg9]-bradykinin, [3H]-Lys-[des-Arg9]BK | |||||
| [3H]Lys-[Leu8][des-Arg9]BK |   |   | 3826 | [3H]-Lys-[Leu8][des-Arg9]-bradykinin, [3H]-Lys-[Leu8][des-Arg9]BK | |||||
| M | Back to top | ||||||||
| maltotriose-[125I][Tyr3,Thr8]octreotide |   |   | 5631 | [125I]-Mtr-TOCA, maltotriose-[125I]-Tyr3-octreotate | |||||
| [3H]maraviroc |   |   | 803 | [3H]UK 427,857, [3H]UK-427,857 | |||||
| [3H]mazindol |   |   | 4591 | [3H]-mazindol | |||||
| [125I]MCH (human, mouse, rat) |   |   | 1296 | [125I]-melanin-concentrating hormone | |||||
| [3H]MCH (human, mouse, rat) |   |   | 3827 | [3H]-MCH, [3H]-melanin-concentraing hormone | |||||
| [3H]MDL105519 |   |   | 4088 | ||||||
| MDP-rhodamine |   | 9506 | MDP-Hex-Rhodamine B | ||||||
| [3H]αβ-meATP |   |   |   | 5405 | |||||
| [3H]meclinertant |   |   | 1583 | [3H]-SR48692, [3H]reminertant, [3H]SR-48692 | |||||
| 2-[125I]melatonin |   |   | 1344 | 2-[125I]MLT, 2-(125I)Iodomelatonin, 2-iodo-[125I]-melatonin, 2[125I]iodomelatonin | |||||
| [3H]melatonin |   |   |   | 1357 | [3H]-melatonin, [3H]MLT | ||||
| [125I][MePhe7]NKB |   |   | 3763 | [125I]-[MePhe7]neurokinin A, [125I]-[MePhe7]NKB | |||||
| [33P]2MeSADP |   |   | 1774 | [33P]2-methylthio-ADP | |||||
| [3H]2MeSADP |   |   |   | 1763 | [3H]2-methylthio-ADP | ||||
| [3H]mesulergine |   |   | 232 | ||||||
| [3H]meta-chlorophenylbiguanide |   |   | 2304 | ||||||
| [14C]metformin |   |   |   | 4503 | [14C]-metformin | ||||
| [3H]methotrexate |   |   |   | 4674 | [3H]-methotrexate | ||||
| [3H]methoxymethyl-MTEP |   |   | 5394 | [3H]-methoxymethyl-MTEP | |||||
| [3H]methoxy-PEPy |   |   | 6425 | ||||||
| [14C]methylamine |   |   | 4624 | [14C]-methylamine | |||||
| [3H](R)-α-methylhistamine |   |   | 1237 | (R)-[3H]α-methylhistamine, [3H]-R-α-Methylhistamine | |||||
| [3H]methyllycaconitine |   |   |   | 3980 | |||||
| [3H]methyltrienolone |   |   |   | 3457 | [3H]-R1881, [3H]R1881 | ||||
| [3H]MeTRH |   |   | 2141 | [3H]Me-thyrotropin-releasing hormone, [3H]pGlu-His(1(τ)-methyl)-ProNH2 | |||||
| [3H]mibolerone |   |   | 3456 | ||||||
| [125I]mini-TyrRS |   |   | 818 | 125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase | |||||
| [3H]mirogabalin |   |   |   | 12597 | |||||
| [125I]MK-678 |   |   | 2061 | ||||||
| [18F]MK-1312 |   |   | 6334 | ||||||
| [3H]MK-912 |   |   | 527 | [3H]L-657,743 | |||||
| [3H]M-MPEP |   |   |   | 1425 | [3H]-M-MPEP | ||||
| MMP13 tracer [18F]5j |   |   | 12669 | ||||||
| [11C]MMTP |   |   | 6212 | ||||||
| [125I]motilin (human) |   |   | 3794 | [125I]-motilin | |||||
| [3H]MRE 3008F20 |   |   | 477 | ||||||
| MRS4174 |   | 9470 | derivative 30 [PMID: 25299434] | ||||||
| MRS4183 |   | 9471 | compound 11 [PMID: 26303895] | ||||||
| [32P]MRS2500 |   |   | 1726 | [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate | |||||
| [3H]MRS1754 |   |   | 453 | [3H]-MRS1754 | |||||
| [3H]MRS2279 |   |   | 1727 | [3H]-MRS2279 | |||||
| MRS4162-BODIPY conjugate |   | 9469 | BODIPY 630/650 conjugate 28 | ||||||
| [14C]MTEP |   |   | 1429 | LS-131849 | |||||
| [3H]muscimol |   |   |   | 4090 | |||||
| Mz438 |   | 12805 | compound 9a [PMID: 37463496], Mz-438 | ||||||
| N | Back to top | ||||||||
| [3H]naloxone |   |   |   | 1676 | [N-allyl-2,3-3H]naloxone | ||||
| [3H]naltriben |   |   |   | 3828 | [3H]-naltriben | ||||
| [3H]naltrindole |   |   |   | 3829 | [3H]-naltrindole | ||||
| Nanoluciferase-labelled relaxin |   | 11464 | |||||||
| NanoLuc-INSL3 |   | 11913 | |||||||
| NanoLuc R3/I5 chimera |   | 11465 | |||||||
| [3H]NBI-49202 |   |   | 1187 | ||||||
| [125I]N-biotin-[Ahx0, Bpa3]U-II (human) |   |   | 9440 | ||||||
| [125I]NDP-MSH |   |   | 1326 | [125I]-NDP-MSH, [125I][Nle4,dPhe7]α-MSH | |||||
| [3H]NECA |   |   |   | 425 | [3H]adenosine-5'-(N-ethylcarboxamide) | ||||
| [3H]nelivaptan |   |   | 3483 | [3H]-SSR149415, [3H]SSR149415 | |||||
| [3H]nemonapride |   |   |   | 962 | |||||
| [125I]neuromedin U-25 (human) |   |   | 1474 | [125I]NmU-25 (human), [125I]neuromedin U, [125I]NMU-25 | |||||
| [125I]neuromedin U-8 (pig) |   |   | 1476 | [125I]NmU-8 (pig), porcine [125I]neuromedin U-8 | |||||
| [125I]neuromedin U-23 (rat) |   |   | 1475 | [125I]NmU-23 (rat), rat [125I]neuromedin U-23 | |||||
| [125I]neurotensin (human, mouse, rat) |   |   | 1574 | [125I]NT | |||||
| [3H]neurotensin (human, mouse, rat) |   |   | 3830 | [3H]-neurotensin | |||||
| [3H]NFPS |   |   | 4619 | [3H]-NFPS | |||||
| [3H]NGD941 |   |   | 3297 | [3H]-NGD941, [3H]NGD 94-1 | |||||
| [125I]NGF (human) |   |   | 4849 | [125I]-nerve growth factor | |||||
| [3H]nicotine |   |   | 3978 | ||||||
| [3H]nicotinic acid |   |   |   | 1594 | [3H]-nicotinic acid | ||||
| [3H]nisoxetine |   |   | 4636 | [3H]-nisoxetine | |||||
| [3H]nitrobenzylmercaptopurine ribonucleoside |   |   | 4511 | [3H]NBMPR, [3H]-NBTI , [3H]NBTI | |||||
| [125I]NKA (human, mouse, rat) |   |   | 3795 | [125I]-neurokinin A, [125I]-NKA | |||||
| [125I][Nle75,Tyr77]apelin-36 (human) |   |   | 603 | ||||||
| [125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat) |   |   | 1791 | ||||||
| [3H]NLX-112 |   |   |   | 3925 | [3H]F13640 | ||||
| [3H]N-methyl-AZ10419369 |   |   | 3219 | [N-methyl-3H3]AZ10419369 | |||||
| [3H]N5-methylfolate |   |   | 6689 | ||||||
| N-[3H]α-methylhistamine |   |   | 1240 | [3H]-Na-methylhistamine, [3H]NAMH | |||||
| N-[3H]methylhistamine |   |   | 1241 | ||||||
| [3H]N-methyl scopolamine |   |   | 317 | [3H]N-methylscopolamine, [3H]NMS | |||||
| [3H]N-methylspiperone |   |   | 196 | [3H]methylspiperone | |||||
| [3H]N-methyl-SSR504734 |   |   | 4603 | [3H]-N-methyl-SSR504734 | |||||
| [3H]4NMPB |   |   | 352 | [3H](1-methyl-4-piperidyl) 2-hydroxy-2,2-diphenyl-acetate, [3H]1-Methyl-4-piperidyl diphenylglycolate, [3H]enpiperate | |||||
| [67Ga]NODAGA-[Tyr3]octreotide |   |   | 5628 | [67Ga]-NODAGA-Tyr3-octreotide, Ga-NODAGATOC | |||||
| [3H]N/OFQ |   |   | 1688 | [3H]nociceptin, [3H]nociceptin/orphanin FQ, [3H]orphanin FQ | |||||
| [35S]non-peptide OT antagonist |   |   | 3484 | [35S]-non-peptide OT antagonist | |||||
| [3H]NPC17731 |   |   | 3831 | [3H]-NPC17731 | |||||
| [125I]NPFF |   |   | 3797 | [125I]-neuropeptide FF, [125I]-NPFF | |||||
| [125I]3-N3-Phpa-LVA |   |   | 2206 | ||||||
| [3H](R)-NPTS |   |   | 4602 | [3H]-(R)-NPTS | |||||
| [3H]NPVF |   |   | 4019 | [3H]-NPVF, [3H]neuropeptide VF | |||||
| [125I]NPW-23 (human) |   |   | 1497 | [125I]neuropeptide W, [125I]neuropeptide W-23, [125I]NPW | |||||
| [125I]NPY (human, mouse, rat) |   |   | 1518 | [125I]neuropeptide Y | |||||
| [3H]NPY (human, mouse, rat) |   |   | 1521 | [3H]neuropeptide Y | |||||
| O | Back to top | ||||||||
| [3H]7-OH-DPAT |   |   | 3296 | [3H]-7-OH-DPAT | |||||
| [3H]8-OH-DPAT |   |   | 31 | ||||||
| [125I]OH-LVA |   |   | 2207 | ||||||
| [125I]orexin A (human, mouse, rat) |   |   | 3798 | [125I]-orexin A | |||||
| [3H]ORG2058 |   |   | 3454 | [3H]-ORG2058 | |||||
| [11C]-ORM-13070 |   |   | 13182 | 11C-ORM-13070 | |||||
| [3H]osanetant |   |   | 3480 | [3H]SR142,801, [3H]SR142801 | |||||
| [3H]OSIP339391 |   |   | 454 | ||||||
| [3H]OT (human, mouse, rat) |   |   | 2176 | [3H]oxytocin | |||||
| [3H]5-oxo-ETE |   |   | 3416 | [3H]-5-oxo-ETE | |||||
| [3H]oxotremorine-M |   |   | 8595 | ||||||
| P | Back to top | ||||||||
| [125I]PACAP-27 |   |   | 2261 | [125I]-PACAP-27, [125I]pituitary adenylate cyclase activating polypeptide-27 | |||||
| [3H]PAF |   |   |   | 1833 | [3H]platelet activating factor | ||||
| [3H]paroxetine |   |   | 4561 | [3H]-paroxetine | |||||
| [3H]PBC-264 |   |   | 899 | [3H]-Propionyl-BC-264, [3H]-Propionyl-BC264, [3H]propionyl-BC-264 | |||||
| PBI-8192 |   | 13996 | |||||||
| [125I]PD142308 |   |   | 3472 | ||||||
| [125I]PD151242 |   |   | 1001 | [125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr, [125I]-PD151242 | |||||
| [125I]PD164333 |   |   | 1002 | [125I]-PD164333 | |||||
| [3H]PD128907 |   |   | 3298 | [3H]PD 128907, [3H]-PD128907 | |||||
| [3H]PD140376 |   |   | 3478 | [3H]-PD140,376, [3H]PD 140376 | |||||
| [3H]pemetrexed |   |   | 6688 | ||||||
| [3H]pentazocine |   |   | 6683 | ||||||
| [18F]PF-06684511 |   |   | 9832 | ||||||
| [3H]PGD2 |   |   |   | 1891 | [3H]-PGD2, [3H]11-dehydroprostaglandin F2-alpha, [3H]prostaglandin D2 | ||||
| [3H]PGE2 |   |   |   | 1916 | [3H]-PGE2, [3H]prostaglandin E2, [3H]prostin E2 | ||||
| [3H]PGF2α |   |   | 1957 | [3H]dinoprost, [3H]prostaglandin F2alpha | |||||
| [125I][Phe13,Tyr19]MCH |   |   | 3844 | [Phe13,[125I]Tyr19]MCH, [Phe13,[125I]Tyr19]melanin-concentrating hormone | |||||
| [125I]p-iodoclonidine |   |   | 13179 | [125I]p-iodo-Clonidine | |||||
| [3H]pirenzepine |   |   | 3272 | [3H]PZ | |||||
| [3H]PL017 |   |   | 3832 | [3H]-PL017 | |||||
| p-[18F]MPPF |   |   | 3227 | [(18)F]p-MPPF, P-[18F]MPPF | |||||
| [3H]p-MPPF |   |   | 81 | ||||||
| [125I][PP1-17,Ala31,Aib32]NPY (human) |   |   | 1559 | ||||||
| [125I]PP (human) |   |   | 3800 | [125I]-pancreatic polypeptide, [125I]-PP | |||||
| [3H]prazosin |   |   |   | 5385 | [3H]-prazosin | ||||
| [3H]pregnenolone sulphate |   |   |   | 6504 | [3H]-pregnenolone sulfate | ||||
| [125I]PrRP31 |   |   | 4022 | [125I]-PrRP31 | |||||
| [125I]PrRP-20 (human) |   |   | 1875 | [125I]prolactin-releasing peptide-20 | |||||
| [125I]psalmotoxin 1 |   |   | 4073 | [125I]-PcTx1 | |||||
| [3H]PSB-0413 |   |   | 6147 | [3H]AR-C67085, [3H]AR-C67085MX | |||||
| [3H]PSB-11 |   |   | 5729 | ||||||
| [3H]PSB-22219 |   |   | 14166 | [3H]18 | |||||
| [3H]PSB603 |   |   | 5728 | ||||||
| [125I]PTA-OH |   |   | 1981 | I-PTA-OH | |||||
| [125I](Pyr1)apelin-13 |   |   | 601 | ||||||
| [11C]pyrilamine |   |   |   | 3957 | [11C]-mepyramine, [11C]-pyrilamine | ||||
| [3H]pyrilamine |   |   | 1220 | [3H]mepyramine | |||||
| [3H](Pyr1)[Met(0)11]-apelin-13 |   |   | 604 | ||||||
| [125I]PYY |   |   | 1519 | [125I]peptide tyrosine tyrosine, [125I]peptide YY | |||||
| [125I]PYY-(3-36) (human) |   |   | 3802 | [125I]-peptide YY(3-36), [125I]-PYY(3-36) | |||||
| [125I]PYY (pig) |   |   | 1520 | [125I]pPYY | |||||
| Q | Back to top | ||||||||
| [3H]QNB |   |   | 318 | [3H]quinuclidinylbenzilate | |||||
| [125I]QRFP43 (human) |   |   | 3803 | [125I-Tyr-32]-QRFP, [125I]-pyro-glutamylated arginine-amide peptide, [125I]-QRFP | |||||
| [3H]quisqualate |   |   |   | 1370 | |||||
| R | Back to top | ||||||||
| [3H]R214127 |   |   | 1391 | [3H]-R214127 | |||||
| [3H]raclopride |   |   | 3299 | [3H]-raclopride | |||||
| [3H]ramatroban |   |   |   | 1910 | [3H]Bay u 3405, [3H]BAY u3405, [3H]baynas | ||||
| [3H]ramosetron |   |   | 2305 | ||||||
| [3H]rauwolscine |   |   | 223 | ||||||
| [125I]relaxin-3-B/INSL5 A chimera |   |   | 3789 | [125I]H3-B/INSL5 A chimera | |||||
| [125I]relaxin-3 (human) |   |   | 1999 | [125I]H3-relaxin (human) | |||||
| [125I]relaxin (human) |   |   | 5398 | [125I]H2 relaxin | |||||
| [33P]relaxin (human) |   |   | 1991 | [33P]H2 relaxin (human), [33P]Human gene 2 relaxin | |||||
| [3H]relcovaptan |   |   | 3482 | [3H] SR 49059, [3H]SR-49059, [3H]SR49059 | |||||
| [125I]resiniferatoxin |   |   | 2492 | ||||||
| [3H]resiniferatoxin |   |   |   | 4091 | |||||
| [3H]resolvin D1 |   |   |   | 4356 | [3H]-RvD1 | ||||
| [3H]resolvin E1 |   |   |   | 2901 | [(3)H]-labeled RvE1, [3H]RvE1 | ||||
| [125I]26RFa (human) |   |   | 10253 | ||||||
| [3H]rimonabant |   |   | 745 | [3H]-rimonabant, [3H]-SR141716, [3H]SR141716A | |||||
| R3/I5- SmBiT |   | 11911 | |||||||
| [3H]Ro154513 |   |   |   | 4365 | |||||
| [3H]Ro 63-0563 |   |   | 3246 | ||||||
| [3H]robalzotan |   |   | 82 | [3H]NAD 299, [3H]NAD-299 | |||||
| [3H]rolipram |   |   | 5313 | [3H]-rolipram | |||||
| [3H]52770 RP |   |   | 1858 | ||||||
| [18F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate |   |   | 3275 | (R,R)-[18F]-FMeQNB, (R,R)-quinuclidinyl-4-[18F]-fluoromethyl-benzilate, (R,R)-quinuclidinyl-4-[18F]-fluoromethylbenzilate(PET ligand), [18F]-FMeQNB | |||||
| [3H]RS 57639 |   |   | 239 | RS57639 | |||||
| [125I]RTI55 |   |   | 5409 | [125I]-RTI55, [3H]β-CIT, [3H]iometopane | |||||
| [3H]RX821002 |   |   | 528 | [3H]2-methoxyidazoxan | |||||
| [3H]RY80 |   |   | 4364 | ||||||
| S | Back to top | ||||||||
| [125I]S36057 |   |   | 1317 | ||||||
| [125I]S70254 |   |   | 7779 | ||||||
| [3H]S0139 |   |   | 3479 | [3H]-S0139, [3H]S-0139 | |||||
| [3H]S-145 |   |   | 1984 | ||||||
| [3H]S-15535 |   |   | 32 | ||||||
| [125I]SAP |   |   | 1982 | [125I]-SAP, I-SAP, Isap acid | |||||
| [125I]sarafotoxin S6b |   |   | 993 | ||||||
| [125I][Sar1]Ang-II |   |   | 6897 | ||||||
| [125I][Sar1, D-Ala8]Ang II |   |   | 12299 | 125I-Sarcosine1, D-Alanine8-Angiotensin II | |||||
| [3H]saredutant |   |   | 3481 | [3H]-SR49868, [3H]SR48,968, [3H]SR48968 | |||||
| [125I][Sar1,Ile8]Ang-II |   |   | 6906 | ||||||
| [125I]sauvagine (frog) |   |   | 916 | ||||||
| [11C]SB207145 |   |   | 3244 | [11C] SB207145 (PET ligand) | |||||
| [123I]SB 207710 |   |   | 3243 | ||||||
| [125I]SB-236636 |   |   | 2710 | ||||||
| [125I]SB258585 |   |   | 3245 | ||||||
| [3H]SB269970 |   |   | 3247 | ||||||
| [3H]SB-674042 |   |   | 1706 | ||||||
| [3H]SB-733993 |   |   | 4491 | [3H]-(2R)-3-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-2-hydroxy-S-(naphthalen-1-yl)propane-1-sulfonamido , [3H]-SB-733993 | |||||
| [125I]SCH23982 |   |   | 945 | [125I]-SCH23982 | |||||
| [3H]SCH-23390 |   |   | 946 | [3H]-SCH23390 | |||||
| [3H]SCH 58261 |   |   | 431 | ||||||
| [125I]SD6 |   |   | 7770 | ||||||
| [125I]secretin (pig) |   |   | 1153 | ||||||
| [3H]senktide |   |   | 3834 | [3H]-senktide | |||||
| 12S-[3H]HETE |   |   | 5508 | ||||||
| [125I]SHU9119 |   |   | 3804 | [125I]-SHU9119 | |||||
| [3H]SNAP-7941 |   |   | 1318 | ||||||
| [32P]S1P |   |   | 5402 | [32P]-S1P | |||||
| [18F]SPA-RQ |   |   | 3473 | [18F]-SPA-RQ | |||||
| [125I]spexin-1 |   |   | 11418 | ||||||
| [125I]SP (human, mouse, rat) |   |   | 3805 | [125I]-SP, [125I]-substance P | |||||
| [3H]SP (human, mouse, rat) |   |   | 3835 | [3H]-SP, [3H]-substance P | |||||
| [3H]spiperone |   |   |   | 3300 | [3H]-spiperone | ||||
| [125I]SQ-29548 |   |   | 1983 | ||||||
| [3H]SQ-29548 |   |   | 1985 | [3H]-SQ29548, [3H]SQ-28053, [3H]SQ29548 | |||||
| [3H]SR 121463A |   |   | 2234 | [3H]-SR121463A | |||||
| [125I]Sta |   |   | 4850 | [125I]-Sta | |||||
| [3H]strychnine |   |   |   | 2360 | |||||
| [3H]sumatriptan |   |   | 119 | ||||||
| [3H]SYM2081 |   |   | 4075 | [(3)H]4MG, [3H](2S,4R)-4-methylglutamate | |||||
| T | Back to top | ||||||||
| [3H]T-516 |   |   | 11449 | ||||||
| [3H]tamoxifen |   |   |   | 5384 | [3H]-tamoxifen | ||||
| TamRLX |   | 11462 | |||||||
| [3H]taurocholic acid |   |   |   | 4546 | [3H]-taurocholate , [3H]-taurocholic acid | ||||
| [35S]TBPS |   |   | 4369 | ||||||
| [3H]TBZOH |   |   | 4766 | α-[O-methyl-3H]dihydrotetrabenazine, [3H]-TBZOH , [3H]dihydrotetrabenazine | |||||
| [3H]-TCS 1102 |   |   | 11527 | [3H]-BBAC, [3H]-compound 18 | |||||
| [14C]TEA |   |   |   | 4575 | [14C]-TEA , tetraethylammonium | ||||
| [3H](+)telenzepine |   |   | 8594 | ||||||
| [3H]2,2,2-TEMPS |   |   | 6328 | [3H]-PAM | |||||
| [125I]tertiapin Y1/K12/Q13 |   |   | 2382 | ||||||
| [3H]thiamine |   |   |   | 4628 | [3H]-thiamine, [3H]vitamin B1 | ||||
| [125I]thyroxine |   |   | 4627 | [125I]-T4, [125I]-thyroxine | |||||
| [3H]tiagabine |   |   |   | 4685 | |||||
| [3H]tiotidine |   |   | 3959 | [3H]-tiotidine | |||||
| [3H]tiotropium |   |   | 8592 | ||||||
| [18F]TM30089 |   |   | 14137 | ||||||
| trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2 |   |   | 3914 | ||||||
| [3H]TRH (human, mouse, rat) |   |   | 3836 | [3H]-thyrotropin-releasing hormone, [3H]-TRH | |||||
| [125I]triptorelin |   |   | 1168 | [125I][D-Trp6]GnRH | |||||
| [125I]TSH (human) |   |   | 3806 | [125I]-thyroid-stimulating hormone, [125I]-thyrotropin, [125I]-TSH | |||||
| [125I]Tyr-Ala-hexarelin |   |   | 1095 | ||||||
| [3H]tyramine |   |   |   | 2148 | [3H]-Tyramine | ||||
| [125I][Tyr4]bombesin |   |   | 623 | [125I-Tyr4]BN | |||||
| [125I][Tyr8]bradykinin |   |   | 3765 | [125I]-[Tyr8]-bradykinin, [125I]-[Tyr8]BK, [125I][Tyr8]BK | |||||
| [125I]Tyr0-CRF (human, rat, mouse) |   |   | 914 | [125I]-Tyr0-corticotropin | |||||
| [125I]Tyr10-CST14 |   |   | 2024 | [125I]-[Tyr10]CST-14, [125I]Tyr10-cortistatin14 | |||||
| [125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH |   |   | 1165 | ||||||
| [125I][Tyr11]des-Br-NPB-23 |   |   | 1498 | [125I][Tyr11]des-Br-neuropeptide B-23 | |||||
| [125I]Tyr4-des-octanoyl-ghrelin |   |   | 3810 | [125I]-Tyr4-des-octanoyl-ghrelin | |||||
| [125I][Tyr26]galanin (human) |   |   | 5391 | [125I]-[Tyr26]galanin | |||||
| [125I][Tyr26]galanin (pig) |   |   | 6117 | ||||||
| [125I][Tyr26]galanin (rat/mouse) |   |   | 5390 | [125I]-[Tyr26]galanin | |||||
| [125I][Tyr4]ghrelin (human) |   |   | 1096 | [125I-Tyr4]-ghrelin, [125I-Tyr4]ghrelin | |||||
| [125I]Tyr45-kisspeptin-15 |   |   | 1280 | [125I-Tyr45]-KP15, [125I-Tyr45]kisspeptin-15, [125I-Tyr45]KP-15 | |||||
| [3H]Tyr14-N/OFQ |   |   | 1687 | [3H]14-Tyr-N/OFQ, [3H]14-Tyr-nociceptin, [3H]14-Tyr-nociceptin/orphanin FQ, [3H]14-Tyr-orphanin FQ | |||||
| [125I]Tyr10NPS (human) |   |   | 1493 | human [125I]Tyr10-neuropeptide S | |||||
| [125I]Tyr0-sauvagine |   |   | 5389 | [125I]-Tyr0-sauvagine | |||||
| [125I](Tyr10)secretin-27 (rat) |   |   | 3759 | [125I]-(Tyr10)secretin | |||||
| [125I]Tyr3 SMS 201-995 |   |   | 2062 | [125I][Tyr3]octreotide | |||||
| [125I]Tyr11-SRIF-14 |   |   | 2060 | [125I]Tyr11-SS-14 | |||||
| [125I]Tyr7-Sst3-ODN-8 |   |   | 2075 | ||||||
| [125I][Tyr3,Thr8]octreotide |   |   | 5630 | [125I]-TOCA, [125I]-Tyr3-octreotate | |||||
| U | Back to top | ||||||||
| [3H]U46619 |   |   |   | 1974 | [3H]U 46619 | ||||
| [3H]U69593 |   |   | 1656 | [3H]-U69593 | |||||
| [3H]UBP310 |   |   |   | 4092 | |||||
| [125I]U-II (human) |   |   | 2158 | human [125I-Tyr9] urotensin-II, human [125I] urotensin-II | |||||
| [125I]urocortin 1 (mouse, rat) |   |   | 917 | ||||||
| V | Back to top | ||||||||
| [3H]valsartan |   |   |   | 593 | |||||
| [3H]vesamicol |   |   | 4758 | [3H]-vesamicol | |||||
| [125I]VIP (human, mouse, rat) |   |   | 2277 | [125I]-VIP, [125I]vasoactive intestinal peptide | |||||
| [11C]volinanserin |   |   | 3249 | [11C]M100907 (PET ligand), [11C]MDL100907 | |||||
| W | Back to top | ||||||||
| [11C]WAY100635 |   |   | 3252 | [11C]WAY-100635, [11C]WAY100635 (PET ligand) | |||||
| [3H]WAY100635 |   |   | 3251 | ||||||
| [3H]WIN35428 |   |   |   | 4605 | [3H]-β-CFT, [3H]-2β-carboxymethy-3β-(4-fluorophenyl)tropane , [3H]-WIN35428 | ||||
| [3H]WIN55212-2 |   |   | 736 | ||||||
| X | Back to top | ||||||||
| [3H]XAC |   |   |   | 432 | [3H]xanthine amine congener | ||||
| [11C]xanomeline |   |   | 3278 | [11C]xanomeline (PET ligand) | |||||
| [125I]XCL1 (human) |   |   | 857 | [125I]ATAC, [125I]lymphotactin, [125I]SCM-1α | |||||
| Y | Back to top | ||||||||
| [3H]YM298198 |   |   | 5392 | [3H]-YM298198 | |||||
| [125I]Y-RFRP-3 |   |   | 1484 | [125I]YVP | |||||
| yttrium (90Y) clivatuzumab tetraxetan |   |   | 8087 | 90Y-hPAM4, hPAM4, hPAM4-Cide, IMMU-107 | |||||
| Z | Back to top | ||||||||
| [3H](S)-zacopride |   |   | 4074 | ||||||
| [125I]ZM-241385 |   |   | 430 | ||||||
| [3H]ZM 241385 |   |   | 455 | [3H]-ZM241385 | |||||
| [3H]zolpidem |   |   |   | 4362 | |||||